Study Objectives: Research points to impaired cognitive performance in sleep clinic patients with obstructive sleep apnea (OSA). However, inconsistent findings from various epidemiologic studies make this relationship less generalizable. The current study investigated the association between OSA and functional outcome measures, such as cognition, daytime sleepiness, and quality of life, in a Korean general population sample. Methods: A total of 1492 participants from the Korean Genome and Epidemiology Study (KoGES) were included in the analyses. The presence of OSA measured by overnight polysomnography (PSG) was defined by apnea-hypopnea index (AHI) >5. Cognitive performance was determined with scores from a comprehensive neuropsychological battery. Excessive daytime sleepiness and quality of life were additionally measured through subjective reports. Results: After adjusting for various demographic and medical characteristics, OSA was independently associated with lower performance in the Digit Symbol Test (52.73 ± 17.08 vs. 58.72 ± 18.03, OSA vs. not, p = .02). Hypoxia measures were not related to cognitive performance. OSA was associated with higher odds of displaying excessive daytime sleepiness (odds ratio = 1.72, 95% CI: 1.05-2.80), but there was no significant relationship between OSA and quality of life. Conclusions: Cognition was unexpectedly unaffected overall. However, OSA was associated with impairment in a multidomain test that taps skills generally associated with frontal lobe function. The results suggest that research on protective and adaptive brain mechanisms to OSA stress can provide unique insights into the brain-sleep interface. As the study runs longitudinally, it will enable future studies on the impact of OSA on cognitive decline.
INTRODUCTION
Obstructive sleep apnea (OSA) is a condition characterized by repetitive obstruction of the upper airway during sleep and is commonly associated with arousals/sleep fragmentation, intermittent hypoxia, inflammatory activation, and dysmetabolism. 1, 2 A negative impact of OSA has been well established in cardiovascular and cerebrovascular diseases 3, 4 as well as metabolic factors, such as obesity and diabetes. 5, 6 OSA is also known to associate with cognitive impairments and poorer performance in domains involving working memory, 7 long-term memory, 8 attention, 9, 10 and executive function. 10, 11 However, much of the data supporting impairment come from severe sleep apnea patients seen in sleep clinics.
A number of different population-based epidemiological investigations have produced inconsistent findings. 2, [12] [13] [14] Authors from the Atherosclerosis Risk in Communities (ARIC) did not find any significant relationship between OSA and attention in cross-sectional analyses, and their longitudinal analyses also revealed no effect of OSA on prospective cognitive performance. 13, 14 In addition, a large randomized controlled trial of continuous positive airway pressure (CPAP) did not find significant cognitive improvement after treatment, but these findings were confounded by high baseline cognitive performance and poor use of CPAP. 12 The current study was conducted in a subset of a general population sample, namely, the Korean Genome and Epidemiology Study (KoGES), with the following objectives: (1) to investigate the association between OSA and performance on a range of cognitive skills; (2) to assess OSA's relationship to excessive daytime sleepiness (EDS) and perceived quality of life; and (3) to explore hypoxia and EDS as potential factors that moderate the relationship between OSA and cognition. Using standard polysomnography (PSG) and a wide range of neuropsychological tests, we aimed to provide rich information on sleep quality and respiration along with comprehensive data on cognitive performance. We also hypothesized that examining a middle-aged population would allow us to determine whether the association between OSA and cognition documented in older adults extends mid-life.
In secondary analyses, we additionally evaluated the level of daytime sleepiness and quality of life to capture the link between OSA and a broad spectrum of day-to-day functioning. EDS is one of the most prominent sequela of OSA, which may also contribute to vigilance and attention deficits commonly found in OSA patients. 15, 16 While previous studies have yielded mixed results about the quality of life in OSA, [17] [18] [19] we hypothesized that cognitive deficits and increased sleepiness in OSA would also decrease the quality of life in individuals with OSA.
STUDY DESIGN AND SAMPLE
The participants for the current study were recruited as part of the KoGES, which is an ongoing prospective cohort study that started in 2001 (baseline examination or "Exam 1"). A total of 5020 original cohort members were followed with biennial examinations that included collection of a range of demographic characteristics, medical history, health status, and sleep-related metrics. The details of the study design and aims have been reported previously. 20 The current PSG protocol was introduced to this study in 2009 (Exam 5), and neuropsychological evaluation was included in 2011 (Exam 6) as KoGES started a substudy on aging. 21 The current study is performed with cohort members whose data were available for analyses, and namely, the subgroup of participants who were randomly selected to participate in both neuropsychological tests and PSG protocols during Exam 6 (years 2011 and 2012).
Of the 3052 cohort members who participated in the core examination during Exam 6, neuropsychological data were available for analysis in 1556 individuals; nocturnal PSG data were available for 1549 individuals who participated in the adjunct study. From those who participated in both studies, we excluded individuals who were lacking information on education attainment (n = 11), had a history of dementia (n = 2), stroke (n = 23), or traumatic brain injury (n = 1). We additionally excluded participants with a Mini-Mental Status Exam (MMSE) score of 23 or below (n = 30) to rule out a confounding effect of dementia and obtained a sample of 1492 for the current analysis. When comparing the current study sample with individuals who were not included in the analysis, those included in the study were generally older, which also explains lower education, lower rate of current smoking, and higher prevalence of hypertension and diabetes seen in this sample (Table 1) . Additionally, there was a higher number of females in the study sample when compared to excluded subjects, due to higher interest and rate of recruitment in women to participate in the adjunct aging study.
Each participant provided an informed consent form, and the study procedure was approved by the Institutional Review Board of the Korea University Ansan Hospital.
PSG Measures
Each participant underwent an overnight PSG with a comprehensive portable device (Embletta® X-100; Embla Systems, Broomfield, CO, USA). Level II PSG (full polysomnogram, unattended, home monitoring) was the primary mode of data collection. Apneas were defined when airflow was reduced to ≥90% of the baseline values for at least 10 seconds; apneas were further classified as obstructive if respiratory efforts were noted on either the chest or abdominal inductance channel, or as central if no respiratory effort was noted. Additionally, hypopneas were defined by a ≥30% reduction in airflow for at least 10 sec accompanied by at least a 4% drop in oxygen saturation (SaO 2 ). The apnea-hypopnea index (AHI) was calculated by averaging the total number of obstructive apneas and hypopneas per hour of sleep, and OSA severity was defined based on different levels of AHI: no OSA (AHI < 5) and OSA (AHI ≥ 5).
All PSG data were scored by two well-trained technicians who had high internal consistency (Cronbach α = .996 and 1.00 for each rater), and strong interrater reliability (Cronbach α = .998). More detailed information on KoGES' PSG administration and scoring has been published previously.
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Neuropsychological Measures
A comprehensive neuropsychological assessment battery was administered during the regular examination cycle, as part of Briefly, verbal and visual memories were evaluated using the Logical Memory and Visual Reproductions from the WMS-III, respectively. Language processing was assessed using Verbal Fluency from the Consortium to Establish A Registry for Alzheimer's Disease (CERAD), which consisted of phonemic and categorical fluency tests. Visual processing and sustained attention were evaluated using the Digit Symbol Test. Sustained attention was measured with Trail Making Test A (TMT-A; number sequencing) and the Stroop Test Letter-Reading paradigms, while TMT B (number-letter sequencing) and Stroop Test Color-Reading paradigms were employed to examine executive functioning. Generally, better performance is indicated by higher total scores, with the exception of timed measures, such as Trails A and B, which indicate the total time of completion.
EDS
Subjective sleepiness was measured using the Epworth Sleepiness Measure (ESS), a widely used, 8-item questionnaire on the participant's likelihood of falling asleep in different situations. 24 The total score is derived from the participant's response to the questions based on a 4-point Likert-type scale. Higher score indicates higher level of daytime sleepiness, and a cutoff score of 11 or higher has been used to determine the presence of EDS. 24 The ESS has been validated in Korean language and has been widely used in this population. 25, 26 Quality of Life During the comprehensive examination, participants answered questions from the SF-12, a short version of the SF-36 health survey questionnaire. 27 The SF-36 is the most widely used questionnaire that measures outcomes of different medical-and health-related conditions. Each of the 12 questions are rated on a 5-point Likert-type scale, and sum of the scores are calculated with a standardized scoring algorithm. Scores are summarized into eight subscales (physical functioning, role physical, bodily pain, general health, vitality, social functioning, emotional role, and mental health). These dimensions can be represented as mental component scores and physical component scores.
Other Covariates
Covariate measures were determined from a health examination and a questionnaire-based interview that were held on-site. Diabetes mellitus was defined as taking insulin or hypoglycemic medication or fasting glucose ≥125 mg/dL. Hypertension was defined with self-reported antihypertensive medication or systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mmHg. Highest level of education (elementary school, middle and high school, college, or graduate school), body mass index (kg/m 2 ), current smoking status (yes/no), and moderate to heavy alcohol consumption (≥ 15 g/day) were also considered for analyses.
Statistical Analysis
General characteristics of study participants were compared between OSA and no-OSA groups using the t test for continuous variables and χ 2 test for categorical variables. For skewed data, the Kruskal-Wallis test was used for continuous variables and the Cochran-Mantel-Haenszel test was used for categorical variables.
To determine the independent effect of OSA on neuropsychological test performance, multiple analysis of covariance was performed after adjusting for possible confounding factors such as age, sex, education, current smoking status, the presence of moderate to heavy drinking, diabetes, and hypertension. Separate analysis was performed for each test measure. The association between the prevalence of EDS and OSA was examined using a multivariate logistic regression analysis.
All analyses were performed using SAS Version 9.4 (SAS Institute Inc., Cary, NC). Results are given as mean ± SD unless otherwise stated. A value of p < .05 was considered to be statistically significant.
RESULTS
Demographics and Subject Characteristics
Demographic characteristics of the study sample are presented in Table 3 by OSA groups. Overall, the mean AHI of the study sample was 7.4 ± 8.4, and among them, 711 (47.7%) were sleep. However, the two groups did not differ significantly in terms of subjective daytime sleepiness or sleep duration.
PSG
The mean AHI of the OSA group was 13.4 ± 8.9, whereas that of the control group was 1.98 ± 1. 
Subjective Sleepiness
To examine the association between OSA and presence of EDS, we examined the distribution and odds ratio (OR) of EDS in OSA (Table 5 Table 1 ).
Quality of Life
Quality of life in OSA was also compared to that of No-OSA group (Table 6 ). Having OSA was associated with marginally lower physical health (50.6 ± 8.9 vs. 51.5 ± 7.8 in No-OSA) and higher mental health score (50.5 ± 8.2 vs. 49.7 ± 8.8 in No OSA; p = .04 and p = .048, respectively) in an unadjusted analysis. However, OSA's association with the mental health score was no longer significant after adjusting for covariates. The physical health score was marginally significant after correction with covariates (p = .06). 
DISCUSSION
In this study that evaluated the cross-sectional association of OSA and cognitive functioning in a community-dwelling, middle-aged, and older adults, we found that OSA was independently associated with poorer performance only in the Digit Symbol Coding test, which is generally considered a more global measure of cognition. A lower score represents a composite index of poorer psychomotor performance, short-term memory, and sustained attention. 28 Only a small proportion of subjects demonstrated EDS in our cohort, but OSA increased the odds. Quality of life was not associated with OSA.
Epidemiological studies analyzing cognitive and psychomotor function in OSA have yielded similar findings, in which the presence of OSA was associated with diminished psychomotor efficiency and sustained attention. 14, 16, 29 A recent cross-sectional study from a large-scale Hispanic/Latino population (n = 8059, mean age = 56, 55% women) found a contradicting result, however, in that the association between OSA and attention was attenuated after adjusting for demographic factors, such as age and education. 2 When examining only females, the authors found that OSA was significantly linked to attention (β = −.061) and other cognitive functions (β = −.37 for verbal learning task and β = −.01 for word fluency) in women (ps < .01). However, this study was limited in that it did not use standard PSG measures and had a limited range of cognitive measures. Our study is unique in that we included a wide range of neuropsychological variables while also measuring OSA using objective, standard measures. We additionally investigated excessive sleepiness and quality-of-life outcomes in an attempt to identify a more general impact of OSA in a largely middle-aged population.
Our finding that OSA is associated with worse scores in a multidomain test that includes attention is consistent with the previous literature. 9, 12, 19, 29, 30 The AHI and hypoxemia are the factors that associate with longer reaction time and the number of omissions in attention and vigilance measures. 12 31 Another study with 298 women (mean age 84) found that hypoxemia had a positive correlation with incident mild cognitive impairment and dementia after a 5-year interval. 32 Intermittent hypoxia can cause impairment in brain function via different mechanisms, including endothelial dysfunction from oxidative stress, 33, 34 disruption of the blood-brain barrier (BBB) and the brain's microenvironment, 35 direct neuronal injury and even amyloidogenesis. 36 In the current study, we found that our parameters of hypoxemia were not correlated exclusively with attentional impairment, despite the significant negative association between OSA and scores on the Digit Symbol. There could be several explanations for this finding. First, hypoxemia in our sample was relatively mild. This level may not be critical enough to create a significant impact on cognitive functioning. Second, there could be neurogenic ischemic preconditioning. 37, 38 Evidence of such compensatory mechanism was previously noted in the clinical setting, where hypertrophy in the hippocampus and increased proliferation in the dentate gyrus were noted in OSA patients, accounting for the partial recovery of brain function. 39 ,40 ARIC's recent null finding on the association between mid-life OSA and adverse brain morphologies in later life may also suggests that there may be a protective mechanisms that reduce OSA's detrimental impact on the brain. 41 Increased central sympathetic drive from hypoxia-induced carotid body-based activation may compensate; for example, in heart failure, daytime sleepiness is inversely correlated with sympathetic drive biomerkers. 42, 43 While our finding is limited by a lack of longitudinal data, it is also possible that the duration and chronicity of OSA would be important determinants for cognitive impact. Another possible explanation for a lack of finding between hypoxemia and cognition in our sample is individual or racial differences in gene × environment interactions. Other explanations linking cognitive impairment in OSA consist of sleep fragmentation and daytime sleepiness. The cognitive deficit seen in OSA is similar to that seen in sleep loss, 44 implying that sleepiness resulting from sleep loss or fragmentation in OSA may cause a general slowing of information processing, which manifests as deficits in attention and vigilance performances. 44, 45 However, previous CPAP studies have shown that cognitive impairment in OSA is only partially reversible with CPAP treatment, even after a full resolution of EDS. 17 This indicates that there may be additional mechanisms-other than sleep fragmentation and persistence of EDS-that contribute to cognitive impairment seen in OSA. 46 In line with this argument is the finding from Shpirer et al.'s study 30 which revealed that EDS was not associated with attentional deficits seen in OSA. Our analysis revealed that the prevalence of EDS is significantly increased in OSA by the odds of 1.53, but we did not see any significant contribution of EDS to cognitive impairment in OSA. That is, EDS did not moderate the attentional deficit seen in OSA (Digit Symbol Coding score 52.9 ± 16.9 in OSA with EDS vs. 50.1 ± 19.1 in OSA without EDS, adjusted P = .83, Supplemental Table 1) .
OSA is likely an example of a chronic stressor that induces adaptive mechanisms and perhaps present to sleep clinics only when that adaptation fails. Chronic partial sleep restriction impairs objective performance more than subjective sense of sleepiness, 47 suggesting that there are domains of adaptation-affective and executive at least. Acute fragmentation or deprivation shows the impact on the brain without an opportunity for adaptation. Interindividual differences in tolerance to sleep fragmentation 48 and sleep deprivation 48 are well known, are likely in part genetic, 49, 50 and could conceivably explain some of the differences noted between clinical and epidemiological investigations. Resistance or susceptibility to sleep stress effects may be one dimension of what is considered cognitive reserve. 51 Such reserve may be dependent on brain networks 52, 53 ; with adequate sample sizes, assessing brain differences in those with substantial sleep apnea but divergent cognitive outcomes may help explain brain resilience to sleep apnea.
It is worth noting that ESS was generally lower in the current sample of Korean middle-aged and older adults compared to other samples of similar age-group with OSA. Compared to a sample of middle-aged Latino/Hispanic adults, our sample was slightly less sleepy (5.0 ± 3.3 in KoGES vs. 5.4 ± 0.1 in the Latino sample) and had significantly lower prevalence of EDS (5.23% in KoGES vs. 17% in the Latino sample). 54 The mean ESS is also noticeably lower in our sample as compared to cohorts of older adults, such as MrOS (mean age = 76.4 and mean ESS = 6.1 ± 3.6) and SHHS (mean age 65, mean ESS 7.7 ± 4.5). 55, 56 The ESS score in OSA was also noticeably lower in our population (5.1 ± 3.4) compared to diagnosed OSA in APPLES (mean ESS = 10.1 ± 4.3). 12 Despite the fact that OSA still associated with the prevalence of EDS in our general population sample, ESS score seems to be lower in our OSA group and in general.
There are several hypotheses for low sleepiness in our data. First, there may be compensatory mechanisms that at this stage of evolution is masking OSA effects both at a sleepiness level and subsequently, and at more complex cognitive level. While it is plausible that subjective sleepiness may represent a marker of compensation and resilience, lack of sleepiness in OSA in this general population sample could reflect that biological perturbations of OSA are within the functional reserve of the brain. A substantial minority of population level sleep apnea patients have minimal to mild subjective daytime sleepiness. 57 Epidemiologic findings have also shown that only a proportion of individuals with severe sleep apnea displayed significant EDS. 56 Another hypothesis is that the low BMI seen in this sample could have alleviated the effect of OSA on EDS. Obesity is a well-established predictor of OSA, but this relationship seems to be less potent in the Asian population. 58 Similarly, we found in our data that individuals with OSA had a nonobese profile (mean BMI = 25), although their BMI was significantly great than that of controls (mean BMI = 23). Given that obesity modifies the relationship between OSA and EDS, it is plausible that the small contribution of obesity in our OSA sample minimized OSA's impact on sleepiness. 59, 60 Lastly, hypoxemia is a strong predictor of EDS in OSA, and mild hypoxia found in our sample could have prevented a significant level of daytime sleepiness that commonly associate with the presence of OSA. 61, 62 Executive Functions Executive function was not independently associated with OSA in the present study, although the OSA group had lower average scores on the Trail Making Test and the Stroop Test than controls. Cognitive deficits resulting from OSA pertain to more basic cognitive process that resemble deficits in sleep deprivation, such as impaired vigilance or processing information. 29, 45, 63 It is also possible that executive functioning is affected by attentional capacity deficits. In our study, we adjusted for attentional measure scores when observing executive function outcomes and found that the association between OSA and executive functioning were not independently associated. Similarly, Lis et al. 63 found from their combined executive function and attention tasks that slower reaction times were attributable to impairments in basic attentional processes additionally involved in executive task solving strategies. It is also notable that, while we did not see domain-specific effects, we found a significant association between OSA and the Digit Symbol, which taps into frontal lobe associated tests more globally.
Quality of Life
Quality of life, as measured by SF-12, was not significantly associated with OSA after adjusting for demographic factors. While the SF-36 is a widely used tool measuring quality of life in OSA patients, findings from previous studies have been inconsistent. 17, 64, 65 The Wisconsin Sleep Cohort Study showed a linear association of OSA severity with reduction of eight subscale scores on the SF-36, and the Sleep Heart Health Study reported similar linear relationships in all scales except for the vitality subscale. 18, 19 A study by Antic et al. 17 did not find any correlation between treatment of OSA and the quality of life; the authors noted that SF-36 may not be adequately sensitive to make meaningful observations in research settings. We used a short-version of the SF-36; therefore, our negative finding may also be in part due to a lack of instrument sensitivity. We also speculate that sociocultural influences on perceived impairment could have also diminished the relationship between sleep and quality of life, given that the link between sleep and sleepiness was also weak in our sample.
Limitations
Our analysis is cross-sectional, and the causation of cognitive impairment in OSA cannot be unequivocally demonstrated. The duration of OSA is also difficult to ascertain from the cross-sectional design, and thus the cumulative exposure to OSA and related risks cannot be determined from our sample yet. Additionally, our measurement of daytime sleepiness or EDS was performed using subjective scales, which may be less accurate as compared to objective recordings from the multiple sleep latency test. Our sample is also not free from selection bias, given that we included a subset of KoGES participants who were part of the aging study. These individuals are generally older, display good response rate to biennial examinations, and may display a healthy volunteer effect. 66 It is also notable that we excluded individuals who scored 23 or lower on the MMSE, which could have created a selection bias in the current sample.
SUMMARY
In summary, the findings from our data show the impact of OSA on a range of cognitive and subjective sleepiness/quality of life measures to be relatively mild. OSA was also independently associated with higher prevalence of EDS, but there was no significant correlation of OSA with perceived physical and mental health-related quality of life. Given that KoGES is a prospective longitudinal study, our future analyses that look at the duration of OSA may reveal important findings about how the chronicity of OSA may have an impact on cognition. Additionally, research that has a focus on adaptive and compensatory mechanisms to the stress of sleep apnea may provide useful new insights.
